Regarding institutional interest, the most recent update available shows 8 to 2 buying lead by Royce who was up to 622k shares while Vanguard added to their position.
I think your thoughts logical in that the combination eventually should make the company far more appealing to institutions as they come to learn more and better understand the transaction. Previous lack of scale was surely an issue that precluded some from investing to date. It's hard to imagine at least a few of them not eventually coming to figure out that with the Marathon Group combo, you get 101 trials in the next two years, a company that generated $93.6 million pro forma combined licensing revenue over last 30 months of operations (unaudited) and $37.5 million pro forma combined licensing revenue over trailing twelve months of operations (unaudited) with 119 defendants and a possible 150 more.
If they can execute, it seems very feasible that Mara Group could far eclipse Acacia from a profits standpoint next year considering it's much lower opex and now improved higher gross margins.
Institutional interest as of last available report for reference.
Ownership Analysis # Of Holders / Shares
Total Shares Held 23 / 1,140,412 New Positions 8 / 749,653 Increased Positions 10 / 781,471 Decreased Positions 9 / 162,693 Holders With Activity 19 / 944,164 Sold Out Positions 5 / 143,551